NBIX Neurocrine Biosciences, Inc.

NASDAQ
$149.50

Neurocrine Biosciences, Inc. (NBIX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below NBIX's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
12 transactions
Purchases
$0
0 shares
Sales
$7.9M
45,479 shares
Net activity
-$7.9M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $7.9M 12 transactions · 45,479 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $1.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
ABERNETHY MATT Chief Financial Officer Sell 10b5-1 2,311 $157.20 $363.3K 42,808 −5.1% of holding
Boyer David W. Chief Corp. Affairs Officer Sell 10b5-1 826 $157.45 $130.1K 8,722 −8.7% of holding
BENEVICH ERIC Chief Commercial Officer Sell 10b5-1 2,154 $154.61 $333.0K 64,408 −3.2% of holding
Norwalk Leslie V Director Sell 10b5-1 1,250 $182.01 $227.5K 1,588 −44% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 4,367 $181.02 $790.5K 16,225 −21.2% of holding
Lippoldt Darin Chief Legal Officer Sell 10b5-1 10,000 $179.60 $1.8M 54,729 −15.4% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 8,433 $178.72 $1.5M 16,225 −34.2% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 2,737 $178.54 $488.7K 16,225 −14.4% of holding
Delaet Ingrid Chief Regulatory Officer Sell 10b5-1 3,401 $178.57 $607.3K 16,225 −17.3% of holding
Lippoldt Darin 2 fills Chief Legal Officer Sell 10b5-1 9,800 $170.16 $1.7M 54,729 −15.2% of holding
Lippoldt Darin Chief Legal Officer Sell 10b5-1 200 $169.56 $33.9K 54,729 −0.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.